At 7.1% CAGR, North America Positive Airway Pressure (PAP) Devices Market is Projected to be Worth US$ 4,296.97 Million by 2031, Says Business Market Insights

According to Business Market Insights' research, the North America positive airway pressure (PAP) devices market was valued at US$ 2,488.80 million in 2023 and is expected to reach US$ 4,296.97 million by 2031, registering a CAGR of 7.1% from 2023 to 2031. Increasing demand for positive airway pressure devices and growing shift toward home healthcare are among the critical factors attributed to the North America positive airway pressure (PAP) devices market expansion.

Positive airway pressure (PAP) devices help keep the airways open while sleeping and result in improved cognitive function and better sleep quality for patients suffering from sleep apnea and respiratory disorders. Innovative PAP devices, such as continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) have been introduced in the market to address the growing need to treat patients with respiratory diseases. The demand for these devices is driven by the rising awareness and diagnosis of sleep apnea, especially obstructive sleep apnea (OSA). The demand is further fueled by the increasing incidence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD). As per WHO, COPD is the fourth leading cause of death globally, responsible for 3.5 million deaths in 2021, which accounts for approximately 5% of all deaths worldwide. Nearly 90% of COPD-related deaths in individuals under 70 years of age occur in low- and middle-income countries (LMIC). Additionally, COPD ranks as the eighth leading cause of poor health worldwide, as measured by disability-adjusted life years. In high-income countries, tobacco smoking is attributed to over 70% of COPD cases. In contrast, in LMIC, tobacco smoking accounts for 30-40% of COPD cases, with household air pollution being a significant risk factor as well. For example, according to the American Lung Association, 11.7 million adults, or 4.6% of the population, had COPD in 2022. Thus, owing to the benefits offered by PAP devices and the increasing incidences of respiratory diseases, the medical and respiratory care market for PAP devices is witnessing noticeable growth.

On the contrary, product recall hampers the growth of North America positive airway pressure (PAP) devices market.

Based on product type, the North America positive airway pressure (PAP) devices market is segmented into automatic positive airway pressure (APAP) devices, continuous positive airway pressure (CPAP) devices, and bilevel positive airway pressure (BiPAP) devices. The continuous positive airway pressure (CPAP) devices segment held 69.0% share of the North America positive airway pressure (PAP) devices market in 2023, amassing US$ 1,717.35 million. It is projected to garner US$ 3,123.01 million by 2031 to expand at 7.8% CAGR during 2023–2031.

Based on application, the North America positive airway pressure (PAP) devices market is segmented into chronic obstructive pulmonary disease (COPD), obstructive sleep apnea, and respiratory distress. The obstructive sleep apnea segment held 78.6% share of the North America positive airway pressure (PAP) devices market in 2023, amassing US$ 1,954.97 million. It is projected to garner US$ 3,487.41 million by 2031 to expand at 7.5% CAGR during 2023–2031.

Based on end user, the North America positive airway pressure (PAP) devices market is segmented into hospitals, ambulatory surgical centers, home care, and rehabilitation centers. The hospitals segment held 54.3% share of the North America positive airway pressure (PAP) devices market in 2023, amassing US$ 1,351.72 million. It is projected to garner US$ 2,487.52 million by 2031 to expand at 7.9% CAGR during 2023–2031.

Based on country, the North America positive airway pressure (PAP) devices market is segmented into the US, Canada, and Mexico. The US held 83.8% share of North America positive airway pressure (PAP) devices market in 2023, amassing US$ 2,085.19 million. It is projected to garner US$ 3,702.28 million by 2031 to expand at 7.4% CAGR during 2023–2031.

Key players operating in the positive airway pressure (PAP) devices market are ICU Medical Inc; React Health (Formerly 3B Medical, Inc); Fisher & Paykel Healthcare Corp Ltd; BPL Medical Technologies Pvt Ltd; Koninklijke Philips NV; Dragerwerk AG & Co KGaA; ResMed Inc; Vyaire Medical Inc; Wellell Inc; Armstrong Medical Ltd; Löwenstein Medical UK Ltd.; BMC Medical Co Ltd; and Narang Medical Limited., among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com